List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 281 studies with search of: Iodide AND NOT radioiodide
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Active, not recruiting Ability of a New Design of Iodine 125 Seed to Maintain Intended Position When Implanted in the Prostate
Condition: Prostate Cancer
Interventions: Radiation: Iodine 125 standard loose brachytherapy seeds;   Radiation: AnchorSeed Iodine 125 brachytherapy prostate implant
2 Active, not recruiting Iodine-131 Anti-B1 Antibody (Tositumomab and Iodine I 131 Tositumomab) for Previously Untreated, Advanced-stage, Low Grade Non-Hodgkin's Lymphoma
Condition: Lymphoma, Non-Hodgkin
Intervention: Biological: Tositumomab and Iodine I 131 Tositumomab (Anti-B1 Antibody and Iodine-131 Anti-B1 Antibody)
3 Recruiting Study of Chlorhexidine Gluconate as a Preoperative Antisepsis
Condition: Surgical Site Infection
Interventions: Drug: Povidone-Iodine;   Drug: Chlorhexidine gluconate
4 Recruiting Comparison of Iodine + Isopropyl Alcohol Versus Iodine + Antimicrobial Sealant for Skin Preparation
Condition: Surgical Site Infection
Interventions: Device: 2-octyl cyanoacrylate [InteguSEAL®];   Device: Iodine povacrylex in isopropyl alcohol [Duraprep®, 3M]
5 Terminated Preventing Lack of Iodine During Pregnancy
Condition: Pregnancy
Interventions: Drug: potassium iodide;   Drug: placebo
6 Not yet recruiting IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients
Condition: Thyroid Cancer
Intervention: Radiation: I131 1.1 GBq
7 Completed Treatment of Epidemic Keratoconjunctivitis With 2% Povidone-iodine
Condition: Viral Conjunctivitis
Intervention: Drug: 2% povidone-iodine
8 Completed
Has Results 		Study of Iodine-131 Anti-B1 Antibody for Patients With Non Hodgkin's Lymphoma Who Have Previously Received Rituximab
Conditions: Lymphoma, Non-Hodgkin;   Non-Hodgkin's Lymphoma
Intervention: Biological: Anti-B1 Antibody and Iodine-131 Anti-B1 Antibody (Tositumomab and Iodine I 131 Tositumomab)
9 Active, not recruiting Lesion Dosimetry With 124-Iodine in Metastatic Thyroid Carcinoma
Condition: Thyroid Cancer
Intervention: Radiation: 131 I-iodine (131-I), 124 I-iodine (124-I)
10 Recruiting A Randomised Controlled Trial of Iodide Supplementation in Preterm Infants Follow-up at 2 Years
Condition: Transient Hypothyroxinemia
Interventions: Drug: sodium iodide;   Drug: sodium chloride
11 Terminated
Has Results 		Comparison Of Rituximab Versus Tositumomab and Iodine I 131 Tositumomab (BEXXAR® Therapeutic Regimen) For Patients With Relapsed Follicular Non-Hodgkins Lymphoma
Conditions: Lymphoma, Non-Hodgkin;   Non-Hodgkin's Lymphoma
Interventions: Biological: Tositumomab and Iodine I 131 Tositumomab;   Biological: Rituximab
12 Completed Testicular Function After Iodine 131 Therapy in Papillary Carcinoma Patients
Condition: Thyroid Neoplasms
Intervention: Drug: Administration of 131 iodine
13 Not yet recruiting The Counter-irritating Efficacy of Topical Povidone-iodine in Thermal Burns
Condition: Skin Burns
Intervention: Drug: povidone iodine
14 Active, not recruiting Iodine I 131 Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Conditions: Anaplastic Large Cell Lymphoma;   Cutaneous B-cell Non-Hodgkin Lymphoma;   Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue;   Nodal Marginal Zone B-cell Lymphoma;   Recurrent Adult Burkitt Lymphoma;   Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Adult Diffuse Mixed Cell Lymphoma;   Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;   Recurrent Adult Immunoblastic Large Cell Lymphoma;   Recurrent Adult Lymphoblastic Lymphoma;   Recurrent Grade 1 Follicular Lymphoma;   Recurrent Grade 2 Follicular Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Recurrent Mantle Cell Lymphoma;   Recurrent Marginal Zone Lymphoma;   Splenic Marginal Zone Lymphoma;   Waldenstrom Macroglobulinemia
Interventions: Drug: cyclophosphamide;   Drug: etoposide;   Radiation: iodine I 131 tositumomab;   Procedure: quality-of-life assessment;   Procedure: peripheral blood stem cell transplantation
15 Active, not recruiting Iodine I 131 Tositumomab and Fludarabine Phosphate in Treating Older Patients Who Are Undergoing an Autologous or Syngeneic Stem Cell Transplant for Relapsed or Refractory Non-Hodgkin's Lymphoma
Conditions: Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue;   Nodal Marginal Zone B-cell Lymphoma;   Recurrent Adult Burkitt Lymphoma;   Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Adult Diffuse Mixed Cell Lymphoma;   Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;   Recurrent Adult Immunoblastic Large Cell Lymphoma;   Recurrent Adult Lymphoblastic Lymphoma;   Recurrent Grade 1 Follicular Lymphoma;   Recurrent Grade 2 Follicular Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Recurrent Mantle Cell Lymphoma;   Recurrent Marginal Zone Lymphoma;   Splenic Marginal Zone Lymphoma;   Waldenstrom Macroglobulinemia
Interventions: Drug: fludarabine phosphate;   Procedure: peripheral blood stem cell transplantation;   Radiation: iodine I 131 tositumomab;   Other: laboratory biomarker analysis;   Other: flow cytometry;   Genetic: polymerase chain reaction
16 Active, not recruiting Retreatment of Patients With Non-Hodgkin's Lymphoma Who Have Previously Responded to Iodine-131 Anti B1 Antibody
Condition: Non-Hodgkin's Lymphoma
Intervention: Biological: Tositumomab and Iodine I 131 Tositumomab
17 Unknown † Expanded Access Study Of BEXXAR® For Low Grade And Transformed Low-Grade Non-Hodgkin's Lymphoma
Condition: Non-Hodgkin's Lymphoma
Intervention: Biological: Iodine I 131 Tositumomab Therapeutic Regimen
18 Recruiting Maternal Iodine Supplementation and Effects on Thyroid Function and Child Development
Conditions: Iodine Deficiency;   Infant Development
Interventions: Dietary Supplement: Placebo;   Dietary Supplement: Iodine
19 Active, not recruiting Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma
Condition: Lymphoma, Mantle-Cell
Intervention: Biological: Tositumomab and Iodine I 131 Tositumomab followed by CHOP
20 Unknown † A Clinical Trial of the Treatment of Fungal Corneal Ulcers With Povidone-Iodine
Conditions: Fungal Keratitis;   Infected Corneal Ulcers
Interventions: Drug: povidone-iodine 1.25% ophthalmic solution;   Drug: natamycin ophthalmic suspension, USP 5%

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services